We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.8B
AUM Growth
+$4.26B
(+7.4%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
23.07%
Holding
1,147
New
131
Increased
370
Reduced
316
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Armstrong World Industries
AWI
|
+$362M |
| 2 |
Procter & Gamble
PG
|
+$347M |
| 3 |
Chevron
CVX
|
+$299M |
| 4 |
Analog Devices
ADI
|
+$240M |
| 5 |
American Electric Power
AEP
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$317M |
| 2 |
Molson Coors Class B
TAP
|
+$279M |
| 3 |
Norfolk Southern
NSC
|
+$213M |
| 4 |
CSX Corp
CSX
|
+$198M |
| 5 |
Medtronic
MDT
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.75% |
| 2 | Healthcare | 13.11% |
| 3 | Financials | 12.08% |
| 4 | Industrials | 11.44% |
| 5 | Communication Services | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
CytomX Therapeutics
CTMX
$675M
| $725K | ﹤0.01% |
+39,200
| New | +$893K |
|
|
IIF
702
Morgan Stanley India Investment Fund
IIF
$217M
| $715K | ﹤0.01% |
30,532
-2,066
| -6% | -$54.2K |
|
703
iShares S&P 500 Growth ETF
IVW
$73.8B
| $713K | ﹤0.01% |
16,120
| – | – |
|
704
RLJ Lodging Trust
RLJ
$1.86B
| $713K | ﹤0.01% |
+32,410
| New | +$721K |
|
705
Gold Fields
GFI
$29B
| $702K | ﹤0.01% |
290,368
-126,359
| -30% | -$380K |
|
|
CBIO
706
Crescent Biopharma
CBIO
$537M
| $696K | ﹤0.01% |
+484
| New | +$732K |
|
|
OSG
707
Octave Specialty Group
OSG
$243M
| $683K | ﹤0.01% |
33,460
| – | – |
|
708
Universal Logistics Holdings
ULH
$353M
| $675K | ﹤0.01% |
+18,355
| New | +$610K |
|
|
MYOV
709
DELISTED
Myovant Sciences Ltd.
MYOV
| $675K | ﹤0.01% |
25,443
+10,954
| +76% | +$248K |
|
|
GCI
710
DELISTED
Gannett Co., Inc
GCI
| $659K | ﹤0.01% |
+65,900
| New | +$675K |
|
711
Stoneridge
SRI
$195M
| $644K | ﹤0.01% |
+21,678
| New | +$687K |
|
712
Acadia Healthcare
ACHC
$2.76B
| $626K | ﹤0.01% |
+17,800
| New | +$709K |
|
713
Five Below
FIVE
$12B
| $619K | ﹤0.01% |
4,767
-165,164
| -97% | -$18.4M |
|
714
Penumbra
PEN
$12.7B
| $617K | ﹤0.01% |
4,125
| – | – |
|
715
Roper Technologies
ROP
$38.8B
| $605K | ﹤0.01% |
2,044
-544
| -21% | -$160K |
|
716
Universal Health Services
UHS
$10.2B
| $603K | ﹤0.01% |
4,719
-771
| -14% | -$94.6K |
|
717
Turning Point Brands
TPB
$1.45B
| $595K | ﹤0.01% |
+14,369
| New | +$505K |
|
718
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
| – | – |
0
| – | – |
|
|
FDC
719
DELISTED
First Data Corporation
FDC
| $552K | ﹤0.01% |
22,572
-1,328
| -6% | -$32K |
|
720
Tenet Healthcare
THC
$20.5B
| $546K | ﹤0.01% |
+19,200
| New | +$634K |
|
|
TFCF
721
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $537K | ﹤0.01% |
+11,738
| New | +$532K |
|
722
NOV
NOV
$6.93B
| $518K | ﹤0.01% |
+12,041
| New | +$539K |
|
723
Broadcom
AVGO
$1.85T
| $515K | ﹤0.01% |
20,910
+410
| +2% | +$9.19K |
|
|
POLY
724
DELISTED
Plantronics, Inc.
POLY
| $502K | ﹤0.01% |
+8,342
| New | +$571K |
|
|
PX
725
DELISTED
Praxair Inc
PX
| $455K | ﹤0.01% |
2,837
-19,425
| -87% | -$3.12M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Lazard Asset Management held 1,147 positions worth $61.8B, up 7.4% from $57.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management's Q3 2018 filing shows 131 new, 370 increased, 316 reduced and 101 closed positions. Its largest new stake was Rogers Communications: 1,642,507 shares worth $84.4M. The largest sale was PG&E, an estimated $317M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Lazard Asset Management's largest Q3 2018 buy was Rogers Communications: 1,642,507 shares worth $84.4M.
- Lazard Asset Management added most to Armstrong World Industries in Q3 2018, an estimated $362M increase.
- Lazard Asset Management's biggest Q3 2018 reduction was PG&E, cutting an estimated $317M.
- Lazard Asset Management fully exited Vipshop in Q3 2018, selling an estimated $46.4M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.8B portfolio in Q3 2018.
- Lazard Asset Management opened 131 new positions and closed 101 in Q3 2018.
- Lazard Asset Management's portfolio value rose 7.4% quarter-over-quarter to $61.8B.
Based on Lazard Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.